More Than $850M Raised for Inflammatory Breast Cancer Research
Susan G. Komen, the Inflammatory Breast Cancer (IBC) Research Foundation, and the Milburn Foundation have joined to raise more than $850,000 for research ... Read more
Updates
-
-
Fertility Clinics and Breast Cancer ‘Previvor’ Team Up to Raise Awareness About Genetic Risk of Disease
For patients with gene mutations that increase their risk for diseases such as breast cancer, fertility and in vitro fertilization (IVF) center Shady Grove Fertility ... Read more -
Blood Test May Identify Breast Cancer Years Before Symptoms Appear, Pilot Study Suggests
A simple blood test – which measures antibodies against certain tumor proteins, or antigens — may identify breast cancer up to five years before ... Read more -
Most Breast Cancers Found by Hand, MammaCare Researchers Say
Decades after establishing the recognized standard for performing and teaching clinical and personal breast exams, the MammaCare Foundation wants women and others to be ... Read more -
First Patient Dosed in Phase 3 Trial of Tucatinib-Kadcyla Combo for Advanced HER2-Positive Breast Cancer
A Phase 3 trial exploring a combination of Seattle Genetics‘ tucatinib plus standard Kadcyla (ado-trastuzumab emtansine) in people with advanced HER2-positive breast cancer ... Read more
-
Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact ... -
Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
Massachusetts pathologist Lija Joseph, MD, has created an innovative program that allows patients, including ... -
Seattle Genetics’ Tucatinib Extends Survival Outcomes in Metastatic HER2-positive Breast Cancer Patients, Phase 2 Trial Shows
People with HER-positive advanced breast cancer who received multiple HER-targeted therapies have significantly better ... -
FDA Supports Use of Anti-diarrheal Medications with Nerlynx
The U.S. label of Nerlynx (neratinib), a treatment for early stage HER2-positive breast cancer, now includes ... -
Bempegaldesleukin-Opdivo Combo Leads to Prolonged Responses in TNBC Patients, Phase 1/2 Trial Shows
Bempegaldesleukin (bempeg, NKTR-214) in combination with Opdivo (nivolumab) leads to prolonged treatment responses in ... -
Daiichi Sankyo Files New Drug Application for DS-8201 in Japan
Daiichi Sankyo has submitted an application to Japanese regulatory authorities asking that its investigational ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU
News
The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more